Do new TB vaccines have a place in the Expanded Program on Immunization?

Expert Review of Vaccines

Volumn 10, Issue 12, 2011, Pages 1675-1677

  McMurray, David N ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

BCG; EPI; TB; vaccine interference

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; MYCOBACTERIAL ANTIGEN 85A; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; GAMBIA; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINE PRODUCTION;

EID: 81355134865     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.144     Document Type: Article

References (9)

1. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3, 656-662 (2005). (Pubitemid 41052152)
2. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 375, 2110-2119 (2010).
3. Rowland R, McShane H. Tuberculosis vaccines in clinical trials. Expert Rev. Vaccines 10(5), 645-658 (2011).
4. Colditz GA, Berkey SC, Mosteller F et al. The efficacy of Bacillus calmette-guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 96(1), 29-35 (1995).
5. Merle CSC, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev. Vaccines 9(2), 209-222 (2010).
6. Roth AE, Stensballe LG, Garly ML, Aaby P. Beneficial non-targeted effects of BCG - ethical implications for the coming introduction of new TB vaccines. Tuberculosis 86, 397-403 (2006). (Pubitemid 44585236)
7. McShane H, Pathan AA, Sanders CR et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10, 1240-1244 (2004). (Pubitemid 39540442)
8. Ota MO, Odutola AA, Owiafe PK et al. Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci. Trans. Med. 3(88), 88ra56 (2011).
9. Lalor MK, Ben-Smith A, Gorak-Stolinska P et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J. Infect. Dis. 199, 795-800 (2009).